MDMA-assisted psychotherapy reduces PTSD in 80% of soldiers, Israeli study finds

The Jerusalem PostIndependentCenter2 hr. ago

An Israeli study published in 2026 found that 80% of soldiers undergoing MDMA-assisted psychotherapy showed reduced PTSD symptoms, with many no longer meeting diagnostic criteria. Conducted at Clalit Health Services' HaEmeek Medical Center, the research highlights growing demand for PTSD treatment amid a 70% increase in diagnoses following the October 7 conflict. Clinical psychologist Ronen Sidi and psychiatrist Dr. Alon Reshef emphasized that MDMA serves as a therapeutic tool rather than a standalone treatment, used in conjunction with 13 sessions of supervised psychotherapy. They noted that early intervention improves recovery outcomes but warned against unsupervised use due to potential risks.

Bias read (Center): The article presents findings from a medical study without overt ideological framing. While it discusses PTSD treatment in military personnel, a politically sensitive issue, it does not take a partisan stance on policies or political figures. The focus remains on medical efficacy and public health, as

i24NEWSIndependentCenteryesterday

A study involving Israeli soldiers has shown a reduction in post-traumatic stress disorder (PTSD) symptoms after participating in therapy sessions that included the use of MDMA, commonly known as ecstasy. The research suggests that MDMA-assisted therapy could be an effective treatment for PTSD among military personnel. The study involved participants undergoing psychotherapy alongside controlled doses of MDMA, which is being explored as a potential therapeutic tool. This approach is part of broader efforts to address mental health challenges faced by veterans and active service members.

Bias read (Center): The article discusses a medical study related to PTSD treatment using MDMA, which is primarily a health-related issue rather than a politically charged topic. There is no indication of bias in the framing or emphasis of the content.